Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Olaf Wrobel has worked on the following 3 EPO patent applications which have been published in the last five years:

EP12748426

PHARMACEUTICAL AEROSOL PRODUCT FOR ADMINISTRATION BY ORAL OR NASAL INHALATION

IPC classification:
A61K 9/00, A61K 9/12, A61K 31/57, A61K 47/10
Applicant:
AstraZeneca AB
Applicant:
Takeda GmbH
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Olaf Wrobel, Takeda GmbH
Status:
GRANT OF PATENT INTENDED
EP15707836

PYRAZINES MODULATORS OF GPR6

IPC classification:
A61K 31/497, A61K 31/5377, A61P 25/00, C07D 241/26, C07D 241/28, C07D 401/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Almut Susanne Elend, Venner Shipley LLP
Agent:
Olaf Wrobel, Takeda GmbH
Status:
EXAMINATION REQUESTED
EP15707835

PYRIDOPYRAZINES MODULATORS OF GPR6

IPC classification:
A61K 31/4985, A61P 25/00, C07D 471/04
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Almut Susanne Elend, Venner Shipley LLP
Agent:
Olaf Wrobel, Takeda GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature